Tonix Pharmaceuticals Holding Corp.
TNXP
$12.83
-$0.33-2.51%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -159.67M | -147.39M | -124.02M | -99.22M | -81.42M |
| Total Depreciation and Amortization | 2.12M | 1.99M | 1.93M | 1.93M | 2.48M |
| Total Amortization of Deferred Charges | 0.00 | 0.00 | 65.00K | 265.00K | -26.00K |
| Total Other Non-Cash Items | 7.52M | 10.80M | 11.81M | 11.03M | 10.20M |
| Change in Net Operating Assets | -2.97M | 9.02M | 10.38M | 11.17M | 3.93M |
| Cash from Operations | -152.99M | -125.58M | -99.84M | -74.82M | -64.84M |
| Capital Expenditure | -5.12M | -5.06M | -3.37M | -1.50M | -545.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 853.00K | -1.16M | -1.16M | -2.01M | -2.01M |
| Cash from Investing | -4.26M | -6.21M | -4.53M | -3.51M | -2.56M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | 0.00 | -9.65M | -10.36M | -11.06M |
| Issuance of Common Stock | 223.24M | 203.07M | 246.69M | 265.89M | 213.89M |
| Repurchase of Common Stock | -7.81M | -10.71M | -13.76M | -5.95M | -5.95M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -7.72M | -7.16M | -8.75M | -9.05M | -8.29M |
| Cash from Financing | 207.71M | 185.20M | 214.53M | 240.54M | 188.59M |
| Foreign Exchange rate Adjustments | -76.00K | -16.00K | -31.00K | 7.00K | -6.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 50.38M | 53.39M | 110.13M | 162.21M | 121.18M |